Concept information
Preferred term
Mercaptopurine
Type
-
mesh:Descriptor
Definition
- An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.
Broader concept
Narrower concepts
Entry terms
- 1,7-Dihydro-6H-purine-6-thione
- 50-44-2 (6-Mercaptopurine)
- 6112-76-1 (monohydrate)
- 6H-Purine-6-thione, 1,7-dihydro-
- 6-Mercaptopurine
- 6-Mercaptopurine Monohydrate
- 6-Thiohypoxanthine
- 6-Thiopurine
- E7WED276I5
- PKK6MUZ20G
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
50-44-2 (6-Mercaptopurine)
-
6-Mercaptopurine
-
6112-76-1 (monohydrate)
-
E7WED276I5
-
PKK6MUZ20G
URI
http://data.loterre.fr/ark:/67375/JVR-KVKLF2PK-D
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}